Price Alert

Sanofi (SNY)

NASDAQ: SNY · Real-Time Price · USD

49.77

0.73 (1.49%)

At close: Aug 15, 2025, 3:59 PM

49.75

-0.05%

After-hours: Aug 15, 2025, 07:35 PM EDT

Sanofi Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	43.13B	43.77B	44.29B	59.54B	58.08B	57.38B	57.13B	45.7B	46.14B	46.2B	45.39B	44.35B	42.04B	40.34B	39.17B	38.5B	37.55B	36.94B
Cost of Revenue	12.24B	12.64B	13.19B	19.12B	18.87B	18.75B	18.39B	13.92B	13.91B	13.89B	13.69B	13.43B	12.84B	12.45B	12.25B	12.17B	12.11B	11.89B
Gross Profit	30.89B	31.14B	31.1B	40.42B	39.21B	38.63B	38.74B	31.78B	32.23B	32.31B	31.7B	30.91B	29.2B	27.89B	26.92B	26.33B	25.44B	25.05B
Operating Income	7.97B	8.12B	7.87B	12.93B	12.51B	12.74B	14.85B	12.68B	15.3B	16.92B	16.49B	15.94B	14.42B	13.99B	13.66B	13.53B	11.83B	11.49B
Interest Income	486.6M	466.6M	482.6M	621M	631M	700M	759M	584M	493M	392M	241M	96M	46M	38M	42M	32M	106M	98M
Pretax Income	7.54B	7.53B	6.68B	9.14B	8.68B	9.04B	10.2B	11.36B	11.01B	10.61B	10.49B	7.82B	8.09B	8.19B	7.82B	7.81B	7.3B	13.99B
Net Income	9.13B	6.3B	5.56B	4.51B	4.22B	4.54B	5.4B	9.07B	8.62B	8.36B	8.37B	6.39B	6.63B	6.67B	6.22B	6.17B	5.81B	12.2B
Selling & General & Admin	8.78B	8.84B	9.22B	13.49B	13.39B	13.27B	13.27B	10.7B	10.77B	10.79B	10.56B	10.43B	10.05B	9.81B	9.62B	9.48B	9.39B	9.33B
Research & Development	7.69B	7.5B	7.41B	8.82B	8.63B	8.55B	8.39B	6.68B	6.75B	6.85B	6.77B	6.54B	6.24B	5.92B	5.69B	5.62B	5.5B	5.46B
Other Expenses	6.46B	6.71B	5.31B	3.89B	1.98B	n/a	793M	1.38B	1.66B	2.56B	2.48B	2.62B	3.01B	2.68B	2.46B	2.19B	1.51B	1.51B
Operating Expenses	22.93B	23.29B	24.12B	28.38B	27.34B	25.97B	24.66B	20.97B	20.23B	20.19B	19.81B	19.58B	19.3B	18.4B	17.77B	17.29B	17.08B	16.97B
Interest Expense	877.84M	925.84M	965.84M	1.74B	1.79B	1.86B	1.77B	868M	653M	552M	472M	419M	403M	414M	425M	298M	211M	199M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.6B	2.6B	4.87B
Cost & Expenses	35.16B	35.92B	37.31B	47.49B	46.22B	44.72B	32.78B	15.63B	3.64B	-7.66B	-7.3B	-9.35B	-7.92B	-6.88B	-6.47B	-5.91B	2.77B	9.66B
Income Tax Expense	1.45B	1.52B	1.2B	2.07B	1.9B	1.87B	2.17B	2.2B	2.24B	2.13B	2.01B	1.36B	1.37B	1.48B	1.55B	1.61B	1.49B	1.78B
Shares Outstanding (Basic)	2.47B	2.47B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B
Shares Outstanding (Diluted)	2.47B	2.47B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B
EPS (Basic)	3.75	2.60	2.30	1.81	1.69	1.82	2.16	2.96	2.79	2.68	2.69	2.56	2.65	2.67	2.49	2.47	2.32	4.86
EPS (Diluted)	3.75	2.60	2.30	1.81	1.69	1.82	2.16	2.96	2.79	2.68	2.69	2.56	2.65	2.67	2.49	2.47	2.32	4.86
EBITDA	9.47B	10.09B	10.18B	11.26B	10.93B	14.75B	15.46B	16.24B	17.64B	17B	16.66B	16.16B	14.76B	11.54B	11.27B	11.43B	10.95B	10.75B
EBIT	8B	8.12B	7.78B	10.64B	10.23B	13.07B	13.86B	12.3B	13.6B	12.98B	12.74B	12.31B	10.87B	8.71B	8.39B	11.22B	10.63B	10.35B
Depreciation & Amortization	1.47B	1.97B	2.4B	5.18B	5.26B	6.24B	5.9B	4.52B	4.42B	4.39B	4.35B	4.37B	4.29B	4.2B	4.14B	4.18B	4.62B	4.91B